Becker's Spine Review

Spine Review_November 2023

Issue link: https://beckershealthcare.uberflip.com/i/1511473

Contents of this Issue

Navigation

Page 19 of 23

20 EXECUTIVE BRIEFING 4 References 1 An HS, Anderson PA, Haughton VM, Iatridis JC, Kang JD et al. (2004) Introduction: disc degeneration: summary. Spine (Phila Pa 1976) 29 (23): 2677-2678. 2 Cihangiroglu M, Yildirim H, Bozgeyik Z, Senol U, Ozdemir H et al. (2004) Observer variability based on the strength of MR scanners in the assessment of lumbar degenerative disc disease. Eur J Radiol 51 (3): 202-208. 3 Michael T. Modic JSR (2007) Lumbar Degenerative Disk Disease. Radiology 245 (1): 4 Donnally IC, Hanna A, Varacallo M Lumbar Degenerative Disk Disease. BTI - StatPearls. 5 Mannion AF, Leivseth G, Brox J-I, Fritzell P, Hägg O et al. (2014) Long-term follow-up suggests spinal fusion is associated with increased adjacent segment disc degeneration but wihtout influence on clinical outcome. Results of a combined follow-up from 4 RCTs: O54 (ISSLS Prize Paper). In: Spine Journal Meeting Abstracts, p 38: LWW. 6 Ekman P, Möller H, Shalabi A, Yu YX, Hedlund R (2009) A prospective randomised study on the long- term effect of lumbar fusion on adjacent disc degeneration. European spine journal 18 (8): 1175-1186. 7 Auerbach JD, Jones KJ, Milby AH, Anakwenze OA, Balderston RA (2009) Segmental contribution toward total lumbar range of motion in disc replacement and fusions: a comparison of operative and adjacent levels. Spine (Phila Pa 1976) 34 (23): 2510-2517. 18 Fritzell P, Hägg O, Wessberg P, Nordwall A, Group SLSS (2002) Chronic low back pain and fusion: a comparison of three surgical techniques: a prospective multicenter randomized study from the Swedish lumbar spine study group. Spine 27 (11): 1131-1141. 19 Garcia R, Jr., Yue JJ, Blumenthal S, Coric D, Patel VV et al. (2015) Lumbar Total Disc Replacement for Discogenic Low Back Pain: Two- year Outcomes of the activL Multicenter Randomized Controlled IDE Clinical Trial. Spine (Phila Pa 1976) 40 (24): 1873-1881. 20 Yue JJ, Garcia R, Blumenthal S, Coric D, Patel VV et al. (2019) Five- year Results of a Randomized Controlled Trial for Lumbar Artificial Discs in Single-level Degenerative Disc Disease. Spine (Phila Pa 1976) 44 (24): 1685-1696. 21 Radcliff K, Zigler J, Braxton E, Buttermann G, Coric D et al. (2021) Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease: 7-Year Results. Int J Spine Surg 15 (4): 612-632. 22 Ravindra VM, Senglaub SS, Rattani A, Dewan MC, Härtl R et al. (2018) Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume. Global Spine J 8 (8): 784-794. Aesculap Implant Systems, LLC, a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of the changing healthcare environment. Through close collaboration with its customers, Aesculap Implant Systems develops advanced spine and orthopedic implant technologies to treat complex disorders of the spine, hip and knee. Aesculap Implant Systems strives to deliver products and services that improve the quality of patients' lives. For more information, visit aesculapimplantsystems.com. 8 Kumar M, Baklanov A, Chopin D (2001) Correlation between sagittal plane changes and adjacent segment degeneration following lumbar spine fusion. European spine journal 10 (4): 314-319. 9 Panjabi M, Henderson G, Abjornson C, Yue J (2007) Multidirectional testing of one- and two-level ProDisc-L versus simulated fusions. Spine (Phila Pa 1976) 32 (12): 1311-1319. 10 Lee CK (1988) Accelerated degeneration of the segment adjacent to a lumbar fusion. Spine (Phila Pa 1976) 13 (3): 375-377. 11 Fritzell P, Berg S, Borgström F, Tullberg T, Tropp H (2011) Cost effectiveness of disc prosthesis versus lumbar fusion in patients with chronic low back pain: randomized controlled trial with 2-year follow- up. European spine journal 20 (7): 1001-1011.' 12 Guyer RD, McAfee PC, Banco RJ, Bitan FD, Cappuccino A et al. (2009) Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up. Spine J 9 (5): 374-386. 13 Delamarter R, Zigler JE, Balderston RA, Cammisa FP, Goldstein JA et al. (2011) Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment oftwo-level lumbar degenerative disc disease: results at twenty-four months. JBJS 93 (8): 705-715. 14 Radcliff K, Spivak J, Darden B, 2nd, Janssen M, Bernard T et al. (2018) Five-Year Reoperation Rates of 2-Level Lumbar Total Disk Replacement Versus Fusion: Results of a Prospective, Randomized Clinical Trial. Clin Spine Surg 31 (1): 37-42. 15 Zigler JE, Delamarter RB (2012) Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease. J Neurosurg Spine 17 (6): 493-501. 16 Fritzell P (2001) Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine 26 2521-2532. 17 Fritzell P, Hägg O, Jonsson D, Nordwall A, Group SLSS (2004) Cost- effectiveness of lumbar fusion and nonsurgical treatment for chronic low back pain in the Swedish Lumbar Spine Study: a multicenter, randomized, controlled trial from the Swedish Lumbar Spine Study Group. Spine 29 (4): 421-434.

Articles in this issue

Links on this page

view archives of Becker's Spine Review - Spine Review_November 2023